AT2 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Atara Biotherapeutics Inc

Watchlist Manager

Watchlist

Price: 8.7975 EUR Market Closed

Market Cap: €19.7B

A	Atara Biotherapeutics Inc SWB:AT2	US
	G Rent SpA F:7F3	IT
S	Suncorp Group Ltd F:SU4	AU
	Also Holding AG F:9AS	CH
E	Eni SpA F:ENI1	IT
	National Vision Holdings Inc NASDAQ:EYE	US
N	NVE Corp F:NVK	US
	C&C Group PLC LSE:CCR	IE
	Safran SA F:SEJU	FR
F	Fiserv Inc SWB:FIV	US
A	ATAC Resources Ltd F:14A	CA
	Medipal Holdings Corp F:59Z	JP
	Surefire Resources NL ASX:SRN	AU
M	Microstrategy Inc F:MIGA	US
	Ely Gold Royalties Inc F:R8N	CA
D	Draegerwerk AG & Co KGaA DUS:DRW8	DE

Profitability Summary

Atara Biotherapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

82%

Strong 3Y Average Gross Margin

54%

Gross Margin is Increasing

2% > 82%

Exceptional Operating Margin

44%

Negative 3Y Average Operating Margin

-1 357%

Operating Margin is Increasing

-455% > 44%

Healthy Net Margin

27%

Negative 3Y Average Net Margin

-1 378%

Net Margin is Increasing

-374% > 27%

Negative Free Cash Flow Margin

-42%

Negative 3Y Average Free Cash Flow Margin

-987%

Free Cash Flow Margin is Increasing

-394% > -42%

Negative ROE

-48%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-116%

ROIC is Increasing

-298% > 142%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.